| Diagnoses in the intervention group (n = 106) | Diagnoses in the control group (n = 105) | ||
---|---|---|---|---|
Final diagnoses, n (%). | Number of 4 h presumptive diagnoses in agreement with final diagnoses, n (%). | Final diagnoses, n (%). | Number of 4 h presumptive diagnoses in agreement with final diagnoses, n (%). | |
Lungs | ||||
 Exacerbation of COPD | 27 (25%) | 24 (89%) | 28 (27%) | 21 (75%) |
 Asthma with exacerbation | 2 (2%) | 0 | 3 (3%) | 2 (67%) |
 Exacerbation in ILD | 3 (3%) | 1 (33%) | 5 (5%) | 0 |
 Pneumonia | 26 (25%) | 23 (88%) | 34 (32%) | 30 (88%) |
 Pulmonary edema | 17 (16%) | 9 (53%) | 6 (6%) | 2 (33%) |
 Parapneumonic effusion | 14 (13%) | 10 (77%) | 14 (13%) | 5 (38%) |
 Empyema | 1 (1%) | 0 | 0 | 0 |
 Pulmonary embolism | 3 (3%) | 3 (100%) | 2 (2%) | 2 (100%) |
 Pneumothorax | 0 | 0 | 1 (1%) | 1 (100%) |
Heart | ||||
 Systolic heart failure | 17 (16%) | 13 (76%) | 22 (21%) | 13 (62%) |
 Non-systolic heart failure | 5 (5%) | 3 (60%) | 1 (1%) | 1 (100%) |
 Acute myocardial infarction | 1 (1%) | 0 | 2 (2%) | 1 (50%) |
Miscellaneous | ||||
 Anemia | 5 (5%) | 1 (20%) | 6 (6%) | 0 |
 Malignancy | 8 (8%) | 2 (25%) | 19 (18%) | 5 (26%) |
 No diagnostic criteria met | 33 (31%) | 19 (58%) | 35 (33%) | 21 (60%) |